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ABSTRACT 
 
BACKGROUND 
 
The concept of Enhanced Recovery After Surgery (ERAS) or Fast Track 
Protocol was pioneered by Bardram. Later popularised by Kehlet and Wilmore, 
ERAS consists of a protocol of interventions aimed at stimulating early recovery 
following surgery and reducing the stress response to surgery thereby reducing 
the morbidity following a major procedure. It was initially tried for elective 
colorectal surgeries. Due the promising results, this protocol has been tried in 
cardiovascular surgeries, urological procedures (radical cystectomy, 
nephrectomy) and is being tried in other specialties as well. Recently some 
studies have been done on the effectiveness of ERAS protocol in upper GI 
procedures. Although most of these studies show promising results by 
reduction in the duration of post-operative hospital stay and also a reduction 
in postoperative complications, some studies show no particular benefit. There 
is no consensus guideline for ERAS in upper GI surgery. Hence more studies 
and meta-analysis is required before the effectiveness can be conclusively 
proven. Also, no studies have been done to find out effectiveness of ERAS 
protocol among Indian population.  
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AIM 
 
To study effectiveness and feasibility of ERAS protocol in patients 
undergoing subtotal gastrectomy for carcinoma stomach in Surgery III unit, 
Christian Medical College, Vellore. 
 
OBJECTIVES 
 
• To study whether ERAS protocol reduces the duration of post-operative 
hospital stay in patients undergoing subtotal gastrectomy in CMC during the 
period of November 2013 to July 2015  
• To study the effect of ERAS on morbidity following subtotal gastrectomy.  
• To study the compliance of study population to ERAS protocol.  
 
METHODOLOGY 
 
This study was a prospective observational cohort study includingadult 
patients with a confirmed tissue diagnosis of adenocarcinoma stomach, who 
underwentelective subtotal gastrectomy in the Surgery III unit at CMC hospital. 
All patients registered for the study followed the modified ERAS protocol 
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which consisted of preoperative, intraoperative and postoperative 
interventions (Table 1).  Patients and their caregivers were counselled about 
the components of the protocol and given a printed hand-out regarding the 
protocol. They were followed up daily after operation to record adherence to 
protocol. If any intervention in the protocol is not followed the reason for the 
same was recorded. These patients were discharged when they satisfied the 
predetermined criteria for discharge. These patients were kept under regular 
follow up for a period of one month to watch for any postoperative 
complications. Primary outcome wasduration of hospital stay and secondary 
outcomes studied included protocol compliance, postoperative complications 
(as per Clavien Dindo classification), day of passage of flatus and faeces 
following surgery, day of initiation of normal diet and any need for 
readmission. 
 
RESULTS 
 
 44 patients were included in the ERAS group and were compared with 
historical controls. The median duration of hospital stay was less in patients 
following the ERAS protocol (6 days) as compared to the historical control 
group who received conventional postoperative care (7 days) however the 
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difference was not statistically significant.  Among the components of modified 
ERAS protocol used, early nasogastric tube removal was the intervention which 
had least adherence due to surgeon preference. ERAS following subtotal 
gastrectomy was not associated with any increase in rate of immediate 
postoperative complications or any increase in morbidity. 
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INTRODUCTION 
 
  Enhanced Recovery After Surgery (ERAS) also known as Fast Track 
Surgery (FTS) or critical pathway (CP) consists of multiple evidence based 
protocols which when followed has proven to reduce the stress response to 
surgery thereby improving the outcome of the procedure and expediting 
recovery. Initially popularised for colonic procedures, this concept has now 
been successfully explored for other major procedures in other branches of 
surgery as well. Few studies have been done to develop similar protocol for 
upper gastrointestinal procedures including gastrectomy with varying results. 
Effectiveness of such a protocol has not been studied on the Indian population. 
This study was aimed to assess the effectiveness of ERAS protocol among 
people undergoing subtotal gastrectomy for carcinoma stomach in Christian 
Medical College, Vellore. Surgery being the mainstay and only curative option 
for carcinoma stomach, this study aims to assess whether following a 
structured ERAS protocol can reduce the duration of hospital stay among 
patients undergoing subtotal gastrectomy and to compare the immediate 
postoperative morbidity among these patients thereby reducing the cost of 
treatment and early return to normal activity.     
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AIMS AND OBJECTIVES 
AIM 
 
To study the feasibility and effectiveness of an enhanced recovery 
(ERAS) protocol in patients with carcinoma stomach undergoing subtotal 
gastrectomy in Christian Medical College (CMC), Vellore during November 
2013 to June 2015. 
OBJECTIVES 
 
1. To study whether ERAS protocol reduces the duration of post-operative 
hospital stay in patients undergoing subtotal gastrectomy in surgery 3 unit, 
CMC hospital during the period of November 2013 to July 2015. 
 
2. To study the effect of ERAS on postoperative complications following 
subtotal gastrectomy.  
 
3. To study the compliance of ERAS protocol among study population. 
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LITERATURE REVIEW 
 
Cancer is a major public health problem in most parts of the world and 
has been attributed to one in four deaths in the United States of America(1). 
Cancer of the stomach contributes a major share of cancer morbidity and 
mortality and affected 6.8% of world population in 2012 alone(2). Stomach 
cancer is currently the fourth most common cancer and is the second most 
common cause of cancer deaths worldwide(3).  
 
GLOBAL EPIDEMIOLOGY OF STOMACH CANCER 
 
 
Stomach cancer was the leading cause of cancer deaths worldwide till 
the 1980s and is currently second to lung cancer. Incidence and mortality of 
stomach cancer has been decreasing over the last two decades which has been 
attributed to various reasons(4,5)(6,7). There is also a significant difference in 
the incidence based on geographical variation. Highest rates of incidence are in 
Eastern Asia, Eastern Europe and South America as compared to low rates in 
North America and most parts of Africa(8).The developing countries bear over 
70% of the stomach cancer burden, especially  Japan and China .The age 
adjusted incidence rates in 2014 were highest in Asia(9).  Another study 
showed incidence rates(per I lakh) ranging from 3.3 and 2.0 in men and women 
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respectively in Egypt to 65.9 and 25.9 in men and women in Korea(10). 
However there have also been reports of increase in incidence of oesophageal 
and gastric cardia malignancies which has been partly attributed to increasing 
gastroesophageal reflux disease as part of obesity and to smoking(11,12).  
 
STOMACH CANCER IN INDIA 
 
 Stomach cancer is one of the leading cause of cancer related deaths in 
India. In a survey by Dikshit et al,Gastric cancer was found to be amongst the 
three most common fatal cancers in India in the age group of 30 to 69 
years(13). Although the incidence of carcinoma stomach in India is less certain 
geographic areas like southern and north eastern India have incidence 
comparable to other high incidence regions of the world(14).According to the 
national cancer registry,the maximum incidence is in Aizwal in Mizoram(15). 
Number of new cases of carcinoma detected per year in India accounts to 
34000 with a male predominance of 2:1 and it is estimated that by the year 
2020 approximately 50000 new cases of stomach cancer will be detected per 
year(13).  
 
 
16 
 
ETIOLOGY OF CARCINOMA STOMACH 
 
 There is a significant geographic and ethnic variation in the incidence of 
carcinoma stomach. There was also a significant variation in the incidence of 
cancer among immigrants based on where they lived. These findings strongly 
suggested modifiable risk factors like diet to be associated with causation of 
carcinoma stomach(16). Processed meat and nitroso compounds are 
associated with an increase in the gastric cancer risk(16) and so are salts and 
salted foods(17). Fruits, vegetables(16,18), lycopene, lycopene-containing 
foods(19), vitamin C, Selenium, legumes, black tea and pulses were found to be 
protective(19). Pickling and  salt-preservation of foods increases the cancer 
risk(17). 
Helicobacter Pylori prevalence closely parallels the cancer incidence and 
lots of research has been published regarding its effect on gastric cancer after 
its first description by Marshal in 1983(20). It is implicated in intestinal 
metaplasia, atrophic gastritis and gastric carcinoma(21), Correa P et all 
proposed that infection with H Pylori initiates a cascade of events including the 
release of oxygen free radicals from the inflammatory cells,leading to 
carcinogenesis(22). In a meta-analysis by Fuccio L et al the eradication of H 
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Pylori was shown to reduce the gastric cancer risk(23). Similar results were 
obtained in studies conducted by Wu CY et al(24) and several others(25–30). 
There is also a possible association between previous gastric surgery and 
gastric cancer which was first noted in 1922 and that the risk was significant 
after 15 years of surgery(31). Strongest association has been found following 
gastrectomy for peptic ulcer disease followed by vagotomy or surgery for 
duodenal ulcer(32–35). 
Ionizing radiations have also been postulated as a causative factor for 
carcinoma stomach. Studies in survivors of the atomic bombings and other 
cohort studies in patients who received radiation for peptic ulcer disease and 
testicular tumours indicate a two to four fold increase in incidence of stomach 
cancers(36–39). 
Hsing et al. observed association between pernicious anaemia and 
stomach cancer with up to three fold risk(40). 
Smoking has been reported to have mild to moderate risk but studies 
have not found association between alcohol consumption and stomach 
cancer(41–48). 
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PATHOLOGY 
 
 Majority of gastric carcinomas are adenocarcinoma (90%). Non Hodgkins 
lymphomas and leiomyosarcomas constitute majority of the remaining 
10%(49).  Other types of cancers include Adenosquamous, squamous, and 
undifferentiated carcinomas. Choriocarcinomas, carcinoid tumors, 
rhabdomyosarcomas, and hemangiopericytomas are the other very rare 
malignant primary tumours. 
 Adenocarcinomas have been classified into intestinal type and diffuse 
type by Lauren in 1965(50). Another classification system used is the WHO 
classification system(51). 
 
Table – 1 Lauren and WHO classification of gastric cancer 
Laurén 
classification 
World Health Organization classification 
Intestinal type Papillary adenocarcinoma 
Tubular adenocarcinoma 
Mucinous adenocarcinoma 
Diffuse type Signet-ring cell carcinoma and other poorly cohesive 
carcinomas 
19 
 
Indeterminate 
type 
Mixed carcinoma 
 Adenosquamous Carcinoma 
Squamous cell carcinoma 
Hepatoid adenocarcinoma 
Carcinoma with lymphoid stroma 
Choriocarcinoma 
Carcinosarcoma 
Parietal cell carcinoma 
Malignant rhabdoid tumor 
Mucoepidermoid carcinoma 
Paneth cell carcinoma 
Undifferentiated carcinoma 
Mixed adeno-neuroendocrine carcinoma 
Endodermal sinus tumor 
Embryonal carcinoma 
Pure gastric yolk sac tumor 
Oncocytic adenocarcinoma 
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STAGING 
 
 Most commonly used staging system for carcinoma stomach was 
developed jointly by the American Joint Committee on Cancer (AJCC) and the 
International Union Against Cancer (UICC) (edited in 2010)(52). Another 
staging system is the Japanese system of classification which is more elaborate 
in terms of anatomical location and lymph node stations(53).  
 
Table 2 – TNM Staging of carcinoma stomach 
Primary tumor (T) 
TX Primary tumor cannot be assessed 
T0 No evidence of primary tumor 
Tis Carcinoma in situ: intraepithelial 
tumor without invasion of the 
lamina propria 
T1 Tumor invades lamina propria, 
muscularis mucosae, or submucosa 
T1a Tumor invades lamina propria or 
muscularis mucosae 
T1b Tumor invades submucosa 
T2 Tumor invades muscularis propria 
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T3 Tumor penetrates subserosal 
connective tissue without invasion 
of visceral peritoneum or adjacent 
structures 
T4 Tumor invades serosa (visceral 
peritoneum) or adjacent structures 
T4a Tumor invades serosa (visceral 
peritoneum) 
T4b Tumor invades adjacent structures 
Regional lymph nodes (N) 
NX Regional lymph node(s) cannot be 
assessed 
N0 No regional lymph node metastasis 
N1 Metastasis in 1-2 regional lymph 
nodes 
N2 Metastasis in 3-6 regional lymph 
nodes 
N3 Metastasis in seven or more 
regional lymph nodes 
N3a Metastasis in 7-15 regional lymph 
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nodes 
N3b Metastasis in 16 or more regional 
lymph nodes 
Distant metastasis (M) 
M0 No distant metastasis 
M1 Distant metastasis 
Anatomic stage/prognostic groups 
Stage 0 Tis N0 M0 
Stage IA T1 N0 M0 
Stage IB T2 N0 M0 
T1 N1 M0 
Stage IIA T3 N0 M0 
T2 N1 M0 
T1 N2 M0 
Stage IIB T4a N0 M0 
T3 N1 M0 
T2 N2 M0 
T1 N3 M0 
Stage IIIA T4a N1 M0 
T3 N2 M0 
23 
 
T2 N3 M0 
Stage IIIB T4b N0 M0 
T4b N1 M0 
T4a N2 M0 
T3 N3 M0 
Stage IIIC T4b N2 M0 
T4b N3 M0 
T4a N3 M0 
Stage IV Any T Any N M1 
Stage IV Any T Any N M1 
 
 
TREATMENT OF CARINOMA STOMACH 
 
 Although new modalities of treatment are under research, resection 
offers the best chance of survival for patients with carcinoma stomach(54,55).  
Surgeries for cancer stomach includes total and partial gastrectomy although 
for early gastric cancers endoscopic treatment is an option(56–58).  Decision 
for type of surgery is made based on the location of cancer where total 
gastrectomy is usually required for tumours involving the upper one third of 
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the stomach(59–63). Japanese classification defines the levels of lymph nodes 
and has been classified to levels based on the stations of lymph nodes which 
have resected(64). 
 
Table 3 – Japanese classification of lymph node stations 
Lymph node 
stations 
Site of node 
No. 1 Right paracardial LN 
No. 2 Lest paracardial LN 
No. 3a LN along the left gastric vessels 
No. 3b LN along the right gastric vessels 
No. 4sa LN along the short gastric vessels 
No. 4sb LN along the left gastroepiploic vessels 
No. 4d LN along the right gastroepiploic vessels 
No. 5 Suprapyloric LN 
No. 6 Infrapyloric LN 
No. 7 LN along the left gastric artery 
No. 8a LN along the common hepatic artery (anterosuperior 
group) 
No. 8b LN along the common hepatic artery (posterior group) 
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No. 9 LN along the celiac artery 
No. 10 LN at the splenic hilum 
No. 11p LN along the proximal splenic artery 
No. 11d LN along the distal splenic artery 
No. 12a LN in the hepatoduodenal ligament (along the hepatic 
artery) 
No. 12b LN in the hepatoduodenal ligament (along the bile duct) 
No. 12p LN in the hepatoduodenal ligament (behind the portal 
vain) 
No. 13 LN on the posterior surface of the pancreatic head 
No. 14v LN along the superior mesenteric vein 
No. 14a LN along the superior mesenteric artery 
No. 15 LN along the middle colic vessels 
No. 16a1 LN in the aortic hiatus 
No. 16a2 LN around the abdominal aorta (from the upper margin 
of the celiac trunk to the lower margin of the left renal 
vein) 
No. 16b1 LN around the abdominal aorta (from the lower margin 
of the left renal vein to the upper margin of the inferior 
mesenteric artery) 
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No. 16b2 LN around the abdominal aorta (from the upper margin 
of the inferior mesenteric artery to the aortic 
bifurcation) 
No. 17 LN on the anterior surface of the pancreas head 
No. 18 LN along the inferior margin on the pancreas 
No. 19 Infradiaphragmatic LN 
No. 20 LN in the esophageal hiatus of the diaphragm 
No. 110 Paraesophageal LN in the lower thorax 
No. 111 Supradiaphragmatic LN 
No. 112 Posterior mediastinal LN 
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Figure 1 – Lymph nodal stations 
 
As per the Japanese classification, all gastrectomies done in our centre were 
either D1 plus (including stations – 1, 3, 4sb, 4d, 5, 6, 7, 8 and 9) or D2 
gastrectomies (includes 11p and 12a also). Nodal stations removed in these 
surgeries are mentioned in the following figure 2(65). 
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Figure 2 – Lymph node stations removed in D1(blue), D1 plus(yellow) and 
D2(red)  Gastrectomy 
 
POST GASTRECTOMY COMPLICATIONS 
 
 Complications following partial gastrectomy may be anatomic, related to 
the extent of surgical resection, physiological, due to the loss of function of the 
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resected segment or due to the type of reconstructive method used. Early 
postoperative complications include bleeding from the anastomotic site, 
anastomotic leak and duodenum stump blowout. Delayed complications 
include post gastrectomy syndromes like early and late dumping syndrome, 
early satiety, gastroparesis, roux stasis. Other possibilities are recurrent 
malignancy, late anastomotic stricture, gastro jejunal intussusception, vitamin 
or mineral deficiencies due to malabsorption. 
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ENHANCED RECOVERY AFTER SURGERY 
 
 The concept of Enhanced Recovery After Surgery (ERAS) also known as 
Fast Track Surgery (FTS) or critical pathway was a concept concieved by 
Bradram et al in 1995 in patients undergoing colonic surgery(66).  It was also 
popularised by articles published by Kehlet and Whilmore(67,68). ERAS 
consists of evidence based protocols which are designed in order to 
standardize treatment and improve outcome by reducing the stress of surgery 
on the patient. ERAS is designed to simulate normal physiological response and 
reduce the adverse response to the stress of surgery thereby expedite 
recovery. It is a multimodal pathway consisting of 
 
 Preoperative strategies 
 Intraoperative strategies 
 Postoperative strategies 
 
The basis of ERAS lies behind the principle that surgery is a stress response 
to which body responds by releasing inflammatory mediators to cope with the 
stress. This stress response usually causes more harm by hampering the 
physiological response to healing. ERAS  protocols are designed to minimize 
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the stress response by mimicking the normal physiological process as much as 
possible like reducing the period of preoperative fasting, reducing the anxiety 
by preoperative counselling and early return of enteral nutrition.  
 
 The concept of ERAS began by the observation by Bardram that post- 
operative complications can be reduced and recovery can be enhanced by 
reducing the stress response of surgery. Bradram in 1995, reported reduction 
in postoperative stay from 8-10 days to 5 days following elective colonic 
surgery with a combination of early enteral feeding and mobilisation, epidural 
analgesia and minimally invasive surgery to reduce the postoperative ileus. In 
his study consecutive 9 patients underwent elective colonic resection for 
malignancy. All surgeries were laparoscopy assisted and they received thoracic 
epidural analgesia postoperatively. All these patients were started on normal 
diet on the day of surgery. There was no increase in postoperative 
complications in these patients. Subsequently other studies reported similar 
advantage with regional anaesthesia, avoidance of drainage tubes, early 
catheter removal and a definitive consensus for fast track surgery was 
formulated in 2009(76). Multiple studies followed including many randomised 
control trials which showed the advantage of ERAS in colorectal 
surgery(69,70). 
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ERAS protocol has been tried successfully in orthopaedic procedures 
(71), Husted et al from Denmark reported a reduction in hospital stay in 
Denmark (11 days to 4 days) following standard procedures like total hip and 
knee replacements. Same protocol was also tried in various urological 
procedures(72,73). Mukhtar et al reported successful implementation of 
critical pathway protocol in patients undergoing radical cystectomy for 
carcinoma bladder thereby reducing hospital stay from 11.5 to 10.4 days. 
There was no increase in complications.Chugthai et al published an advantage 
in postoperative stay for patients undergoing nephrectomy when ERAS 
protocol was followed. Various gynaecological procedures like hysterectomy 
have also been found to be benefited after implementation.(74,75). 
 
In 2009, Lassen et al reviewed the articles published till then on ERAS 
pathway following colorectal procedure and proposed a 20 point consensus 
guideline for ERAS in colorectal procedures, 
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1. Counselling and information 
 
Patients should be explained about the procedure, post-operative 
careand pain relief. Adherence to the protocol can be ensured only if the 
patient has been explained about the targets for postoperative food 
intake and ambulation(77).  
 
2. Preoperative bowel preparation 
 
For colonic procedures, routine mechanical bowel preparation 
was not found to be useful in many randomised control trials moreover 
few studies moreover few studies had even found out that preoperative 
bowel preparation led to increased risk of anastomotic leak and a higher 
morbidity and mortality(78). It was also suggested that bowel 
preparation prolonged postoperative ileus(79).   
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3. Carbohydrate loading and preoperative fasting 
 
Cochrane review of 22 RCTs has proven that fasting status of 2 
hours for clear liquids and 6 hours for solid food does not increase any 
morbidity(80). This is based on normal gastric emptying time. However 
in diabetics there is delayed gastric emptying due to neuropathy.  
There have also been studies which have proven better outcome and 
reduced postoperative complications if a patient undergoes surgery in a 
carbohydrate fed state. This is achieved by giving the patient clear 
carbohydrate rich drink 2-3 hours before surgery. This has proven to 
have a positive effect on postoperative insulin resistance as well as 
nitrogen losses and lean body mass postoperatively(81). 
 
4. Pre anaesthetic drugs 
 
Long acting opioids or sedatives when given as premedication for 
procedure has been proven to prolong postoperative hospital stay by 
hampering the oral intake after recovery from surgery. Short acing 
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anxiolytics were recommended as premedication instead of long acting 
medications. 
 
5. Thromboprophylaxis 
 
Both unfractionated heparin and low molecular weight heparin 
have been proven to be effective in preventing thromboembolic 
phenomenon  and have been proven to be safe even when used along 
with epidural analgesia and the risk of haematoma is not increased. 
 
6. Antibiotic prophylaxis 
 
The guidelines for colorectal surgery advocates the use of gram 
positive antibiotic (preferably second generation cephalosporin) along 
with metronidazole as prophylactic antibiotic one hour prior to the 
incision. Antibiotic dose is advised to be repeated in case the surgery is 
prolonged for more than 3 hours. 
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7. Anaesthesia Protocol 
 
Preferable use of short acting anaesthetic agents. Mid thoracic 
epidural analgesia which blocks sympathetic outflow along with 
analgesia without causing gut paralysis. Epidural anaesthesia during the 
surgery prevents postoperative insulin resistance and attenuates the 
stress response. 
 
8. Preventing Hypothermia 
 
Various randomised controlled trials have proven that prevention 
of hypothermia reduces bleeding and complications, perioperative 
cardiac complications and wound infections(82,83).  
 
9. Intraoperative fluid management 
 
According to conventional management, patients received fluids 
intraoperatively much more than their losses ultimately resulting in fluid 
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overload and causing increased complications including anastomotic 
complication and wound infections and resulting in prolonged hospital 
stay. Restricted fluid therapy and goal directed fluid therapy along with 
intraoperative monitoring of cardiac output has been proven to have 
less postoperative complications(84).  
 
10. Minimally invasive surgery 
 
Recent meta-analysis has confirmed that minimally invasive 
laparoscopic assisted procedures have earlier recovery in terms of return 
of function of the bowel as well as considering duration of hospital stay. 
A study by King et al studied the effect of laparoscopic versus open 
surgery in the setting of ERAS for colonic surgeries and found that there 
was no statistically significant improvement in duration of hospital 
stay(85) however more studies are awaited in this regard. 
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11. Prevention of postoperative vomiting 
 
Factors which are associated with increased risk of postoperative 
nausea and vomiting include female gender, postoperative opioids, past 
history of motion sickness and non-smoking individuals. Patients with 
two of these risk factors have been found to have increased risk of 
postoperative vomiting and it has been proven to be beneficial in these 
patients to give dexamethasone during induction and to continue 
serotonin inhibitors during the postoperative period(86).    
 
12. Role of nasogastric tube 
 
It is proven that prophylactic nasogastric tube insertion during 
abdominal surgeries has no advantage especially in colonic 
surgeries(87). Return of gastrointestinal function has also been found to 
be early in patients whom nasogastric tube was avoided. Moreover it 
has also been proven that nasogastric tube increases the chance of 
aspiration during the procedure. 
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13. Use of intraabdominal drains 
 
A meta-analysis by Karliczek et al proved that prophylactic drain 
placement did not reduce the incidence or severity of anastomotic leaks 
following colonic anastomosis. Thus in the protocol for ERAS, consensus 
is to avoid drains unless there isspecific indication.  
 
14. Urinary catheter 
 
Early removal of urinary catheter is advocated in order to prevent 
urinary tract infections and to facilitate early ambulation. 
 
15. Postoperative analgesia and prevention of ileus 
 
These form the main stay of ERAS protocol. Mid thoracic epidural 
is ideal as it provides adequate pain relief for 2 - 3 days and prevents 
ileus as compared to opioids. Adequate pain relief is essential for 
ambulation of the patient and for prevention of postoperative lung 
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complications. Nonsteroidal anti-inflammatory agents are preferred for 
top up analgesia as compared to opioids.Epidural analgesia attenuates 
the sympathetic stress response to the surgery without affecting bowel 
motility. Multiple studies have retained epidural analgesia for different 
durations and removal of epidural has to be timed with the dose of 
anticoagulant with a gap of at least 6 hours in order to prevent 
haematoma. 
 
 
16. Postoperative nutrition 
 
There is strong evidence to prove that, early enteral nutrition 
when compared to keeping the patient nil per oral for prolonged 
duration has better outcome in terms of reduced complication and 
reduced duration of hospital stay. There is also evidence to prove that in 
patients started on early enteral nutrition, nitrogen balance is more 
maintained and chances of postoperative insulin resistance is also less. 
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17. Early ambulation 
 
Early ambulation is of prime importance in preventing muscle loss, 
improving oxygenation and preventing thromboembolism. Early 
ambulation can be facilitated by early removal or avoidance of drains 
and urinary catheter and adequate pain relief. 
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ERAS IN GASTRECTOMIES 
 
 As ERAS was successful in colorectal surgeries,there have been studies 
which have tried to incorporate the same principles to gastric 
surgeries.Suehiro et al in 2004 published regarding advantages of early enteral 
feeding. The study proved that initiation of enteral diet within 48 hours of 
gastrectomy was safe and that the postoperative stay was shorter with return 
of bowel functions earlier in this group(88).Two similar randomised control 
studies proved that nasogastric compression was not beneficial after surgeries 
for cancer stomach. Time to passage of flatus and faeces and duration of 
postoperative hospital stay was significantly more in patients who had 
nasogastric tube. Also 72 percentage of patients had discomfort due to the 
tube(89,90). A study by Alvarez et al showed that drains after surgery on 
stomach was not required. These studies paved the way towards trial of ERAS 
in gastrectomies. 
 
 Wang et al in 2010 and similar study by Tang et al reported accelerated 
recovery and shortened hospital stay in patients following fast track protocol 
after gastrectomy. Another study by Yamada et al also concluded that ERAS 
protocol was useful in patients undergoing gastrectomy(91–98).As there was 
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no standard recommendation for ERAS protocol in gastrectomy, these studies 
adapted the guidelines from colorectal surgery and modified it to suit upper 
gastrointestinal surgery. These studies had variations in the protocol followed 
and guidelines for fasting and carbohydrate feeds till 2 hours prior to surgery 
were not followed for gastrectomy. Few studies during this period did not 
show any particular benefit after application of enhanced recovery 
protocol(99). A study by Jeong et al reported no benefit in duration of hospital 
stay or cost when critical pathway was followed for patients undergoing 
gastrectomy(100) however majority of studies performed later on proved that 
ERAS protocol reduced the postoperative complications as well as duration of 
hospital stay. 
  
Although there have been a few randomised controlled trials there are 
only two recently published meta-analysis available regarding FTS in gastric 
surgery. A recent meta-analysis by Chen et al which compared multiple studies 
published regarding ERAS in gastrectomy and reported that the postoperative 
hospital stay was significantly shorter in ERAS group compared to the 
conventional group(101). Considering the lack of standard guideline for ERAS 
and considering the reason that all studies published till now had based their 
protocol on modification of the guidelines for colorectal surgery, studies which 
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followed at least 7 out of the 20 guidelines mentioned in the 2009 consensus 
were included in the ERAS group(102). In the study, 7 RCTs were included with 
a total of 524 patients. There was a wide variation in the protocols followed 
with one RCT following epidural for analgesia and two studies used local 
infiltration as mode of pain relief. However all studies avoided long acting 
opioids as a method of analgesia. Two among the seven studies were for 
laparoscopic gastrectomies and the remaining were for open procedures. 
Analysis showed that there was significant reduction in the postoperative 
hospital stay (reduction by 2.6 days) in the  FTS group also there was a 
significant reduction in expenditure. Postoperative morbidity and readmission 
rates were comparable among the groups. Chen et al however reported that 
FTS should be selectively used in patients as most of the published studies had 
excluded patients with significant comorbidities and ASA more than 2 and 
when patients were malnourished. 
 ERAS protocol for gastrectomy is still subject to evolution in terms of 
component modification and clinical significance. Another vital aspect of 
success of FTS is the requirement of cooperation between the multidisciplinary 
team involving the surgeon, anaesthetist, nursing staff, physiotherapists and 
the caregivers. 
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METHODOLOGY 
STUDY SETTING 
 
This study was conducted in the department of Surgery, unit III, Christian 
Medical College Hospital, and Vellore. 
 
STUDY DURATION 
November 2013 to July 2015 
 
STUDY DESIGN 
 
The study was an observational cohort including patients with diagnosed 
adenocarcinoma stomach and were undergoing partial gastrectomy under the 
department of surgery 3 in Christian Medical College Hospital, Vellore. 
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INSTITUTIONAL REVIEW BOARD AND ETHICS COMMITTEE 
APPROVAL 
 
The study design and the methodology was assessed by the institutional 
review board and the ethics committee and duly approved. The copy of the 
approval form is enclosed (Annexure - 1). 
CONSENT 
 
Patients diagnosed with carcinoma stomach and planned for subtotal 
gastrectomy were invited to take part in the study and the informed consent 
was presented in the native language. The consent forms used in the study is 
enclosed. (Annexure - 2) 
 
INCLUSION CRITERIA 
 
 All adult patients with a confirmed tissue diagnosis of adenocarcinoma 
stomach, who underwent elective subtotal gastrectomy at the Surgery 3 unit in 
CMCH during the study period were included.  
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EXCLUSION CRITERIA 
 
• Patients with clinical and radiological evidence of complete gastric 
outlet obstruction  
• Patients undergoing emergency gastrectomy due to gastric perforation 
of an underlying malignancy.  
• Patients requiring ICU admission immediate post OP due to co-morbid 
illnesses.  
SAMPLE SIZE 
 
 Primary outcome of the study is duration of postoperative stay. On an 
average a patient stays in CMC following a subtotal gastrectomy for average of 
7.9 days with a standard deviation of 2.5 days. Based on previous studies 
expected reduction in postoperative stay is 2 days with standard deviation 
ranging from 1.2 days.  
 
Formula for calculation  
 
 
N= 2 x (Z(1-α/2) + Z(1-β) )
2 x σ2    σ2 = S12 + S22 
D2       2  
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Expecting a difference of two days in the duration of hospital stay 
between patients following ERAS protocol when compared to the duration 
when ERAS is not applied, minimum sample size was calculated to be 31 for a 
study with power of 90% and an error of 1%. 
Institution Review Board (IRB) approval was obtained prior to recruiting 
patients.  
 
 
ERAS PROTOCOL AND METHOD OF DATA COLLECTION 
 
 All patients admitted in surgery 3 unit with a diagnosis of 
adenocarcinoma stomach and planned for subtotal gastrectomy were 
counselled regarding the study protocol and recruited. They were given 
handouts in their native languages which explained the protocol in detail 
(Annexure – 3). As there are no definite guidelines for ERAS protocol in upper 
gastrointestinal procedures, a protocol was developed based on the available 
guidelines for colonic procedures, and approved by the IRB.     
The protocolentailed:  
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1. Preoperative interventions 
Preoperative interventions consisted of counselling and information to the 
patients regarding ERAS protocol and the surgery. All patients were given 
preoperative thromboprophylaxis in the form of heparin and were provided 
with thromboembolic deterrent stockings. They were started on incentive 
spirometry and also counselled regarding cessation of smoking and consuming 
alcohol. 
 
2. Intraoperative interventions 
All the recruited patients underwent standard surgical procedure – subtotal 
gastrectomy with D1 plus or D2 lymph nodal clearance. They received 
prophylactic antibiotics – cephazolin, gentamicin and metronidazole during 
induction, as per the unit protocol. All patients received general anaesthesia 
with thoracic epidural analgesia with bupivacaine and fentanyl which was 
continued postoperatively and administered through premixed syringes. Type 
of resection, whether curative of palliative, intraoperative adverse events if 
any were monitored along with intravenous fluids administered during the 
procedure and blood loss were recorded. 
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3. Postoperative interventions 
These interventions included targets regarding oral feeding and ambulation for 
each postoperative day. Nasogastric tube was supposed to be removed within 
24 hours along with starting of sips of fluids on the same day of operation. 
Patients were also encouraged to sit up on the same day of surgery followed 
by progressive ambulation on each day. Oral sips were increased on second 
postoperative day and progressed to fluids as tolerated by fourth 
postoperative day. They were started on solid diet by fifth postoperative day. 
Postoperative pain relief was achieved by epidural infusion with addition of 
non-steroidal anti-inflammatory drugs or opioids if pain relief was inadequate 
as per decision of operating surgeon. Epidural infusion was continued till 
fourth postoperative day if it was effective and was removed along with 
removal of urinary catheter. 
 
Protocol for ERAS (Table 4) 
PREOPERATIVE 
• Counselling the patient and relatives regarding the disease, 
proposed surgery, protocol for ERAS and its advantages. ( 
handout) 
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• Counselling patients to quit smoking and alcohol use.  
• Training patients to do incentive spirometry. 
• First dose of DVT prophylaxis. 
 
 
INTRAOPERATIVE 
• Anaesthesia – Endotracheal intubation and GA + Thoracic Epidural 
(Fentanyl + Bupivacaine). (other modes of regional analgesia if 
needed) 
• Antibiotic prophylaxis at induction of anaesthesia. 
• Avoid hypothermia during surgery 
• Intra OP fluid restriction. (in conjunction with anaesthetist) 
• Avoid NG tube and drains whenever possible (unless specifically 
deemed necessary) 
 
POSTOPERATIVE 
• Perioperative oxygen therapy – till 6hours post OP 
• Incentive spirometer once the patient is awake. 
• Analgesia – thoracic epidural analgesia ((Fentanyl + Bupivacaine)) 
+ intravenous paracetamol (Inj Febrinil) till 48 hours. Add on non-
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opioid analgesics if pain scores more than 5 on a visual analogue 
score.  
• Diet – start on few sips of clear fluids on day of surgery followed 
by liquid diet from day 2 progressing to soft solid diet from day 4. 
• Removal of NG tube (if present) – within 24 hours 
• Removal of Urinary catheter – within 48 hours (along with 
epidural) 
• Ambulation – mobilize to chair on day of surgery, start 
progressive ambulation from  
day 2. 
• Continue DVT prophylaxis. 
Type of surgery and the limit of resection – standardized  
 
 Patients were considered to be fit for discharge when they satisfied the 
criteria for discharge (Table - 2). The day of passage of flatus and stool was also 
recorded for each patient.   
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Table 5 - Criteria for discharge 
 
  
 
 
Patients included in the study group were followed up postoperatively and 
adherence to the ERAS protocol was observed. Any deviation from the 
protocol was noted along with the reason for the same. Postoperatively these 
patients were followed up till discharge for any immediate complications and 
later on as outpatient for any delayed complications. Complication was 
classified according to the Clavien Dindo classification system(103).  
 
ANALYSIS 
 
Data was collected by interview technique using questionnaire for the 
demographic details and adherence to protocol was recorded. (Annexure - 3) 
Patients were followed up till their immediate postoperative outpatient visit. 
Data regarding adherence to ERAS protocol was collected by daily 
 Normal body temperature, 
 Pain controlled with oral analgesics, 
 Mobilizing comfortably 
 Adequate oral diet  , without parenteral fluids 
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postoperative follow up and entered on investigation form ( Annexure - )  Data 
was entered using epidata software and analysed using STATA software. 
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RESULTS 
 
Forty four patients diagnosed with adenocarcinoma of distal stomach 
were recruited prospectively for the study. They were counselled regarding the 
study protocol. According to the protocol they were given preoperative 
incentive spirometry and thromboprophylaxis, intraoperative events were 
recorded and postoperative targets as per the protocol were monitored. Their 
adherence to the protocol was recorded and were followed up till discharge 
and first outpatient follow up. Any deviation from the protocol was recorded 
along with the reason for the same. This was compared to historical controls 
from the previous year for whom data was collected from the inpatient charts. 
The results were analysed as  
 
1. Demographic parameters in both groups 
 
2. Effectiveness of ERAS protocol 
 
3. Adherence to ERAS protocol 
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DEMOGRAPHIC PARAMETERS 
 AGE 
Mean age among the ERAS group was 54.09 as compared to 50.50 in the 
control group (Table 1). 
Table 1 – Age distribution 
Group Mean Age Standard deviation 
ERAS 
Group 54.09 12.16 
Control 
Group 50.5 13.47 
 
 GENDER 
Both ERAS group and the control group consisted of more males as 
compared to females. (Table -2, Fig – 1)  
Table 2 – Gender distribution 
Gender Male Female 
ERAS Group 30 14 
Control 
Group 26 15 
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 FITNESS STATUS OF PATIENTS  
Among the patients studied in the ERAS group and the control group, 
general fitness was assessed with the American Society of Anaesthesiologists 
(ASA) status score for physical fitness. 
 
ERAS GROUP
Male Female
Control Group
Male Female
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Table 3 – ASA status of patients in study 
ASA Status ERAS group Control Group 
1 27 26 
2 16 13 
3 1 1 
 
 
 
 
ERAS group
1 2 3
Control group
1 2 3
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 COMORBID ILLNESSES 
 
Among the ERAS group, three out of the forty four patients had diabetes. 
One among the group had hypertension. Five patients had other comorbidities 
which included hypothyroidism and bronchial asthma. 
0
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60 
 
 
 
 
DISEASE CHARECTERISTICS 
 
All patients in the ERAS and control group were diagnosed to have 
adenocarcinoma of the distal stomach.  
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 DURATION OF SYMPTOMS 
Among the patients in ERAS group, average duration of symptoms prior to the 
operation was 9.55 months. 
Duration of Symptoms Mean Standard Deviation 
Months 9.55 12.37 
 
 
 Type of resection 
Thirty eight of the forty four patients underwent curative resection, however 
six patient had palliative resection. 
 
 
Type of resection
Curative Paliative
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EFFECTIVENESS OF ERAS 
 
Duration of postoperative hospital stay was calculated from the day 
surgery to the day when they were fit for discharge. Median duration of stay in 
the ERAS group was found to be 6 days and in the control group was 7 days. 
On analysis with Mann-Whitney test the difference in hospital stay was found 
to be not significant (P value – 0.055). 
Table 5 – duration of postoperative hospital stay 
 25th centile Median stay 75th centile 
ERAS group 5 days 6 days 7 days 
Control group 5.5 days 7 days 8 days 
 
 On analysis of duration of total hospital stay from the date of admission 
to the date of discharge, median stay in the ERAS group and control group was 
8 days and 9 days respectively but the difference was not statistically 
significant (P value – 0.056). 
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Table 6 – Total duration of hospital stay 
Total duration of 
hospital stay 
25th centile Median stay 75th centile 
ERAS group 7 days 8 days 10 days 
Control group 8 days 9 days 12 days 
 
 
 
ADHERENCE TO ERAS PROTOCOL 
 
 PREOPERATIVE STRATEGIES 
Adherence to preoperative protocol was 100 percentage. All patients 
were counselled about the procedure and about postoperative targets. They 
0
2
4
6
8
10
ERAS Group Control Group
Duration of hospital stay
75th Centile 25th Centile Median
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were also started on incentive spirometry, and received prophylactic dose of 
heparin as thromboprophylaxis. Patients with smoking and alcohol 
consumption were advised cessation of the same. 
 
Protocol Adherence 
1. Preoperative counselling and 
information 
100% 
2. Advice regarding cessation of 
stoppage of smoking and 
alcohol 
100% 
3. Incentive spirometry 100% 
4. Preoperative heparin 
prophylaxis 
100% 
 
  
 INTRAOPERATIVE STRATEGIES 
 
All patients received general anaesthesia plus thoracic epidural analgesia 
with bupivacaine and fentanyl. They also received one dose of prophylactic 
antibiotic (cephazolin + gentamicin + metronidazole) at the time of induction. 
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They were monitored throughout the procedure with temperature probe and 
none of the patients had any evidence of hypothermia. 
 
Intraoperative strategy  Adherence in patients 
1. Anaesthesia – GA + epidural 100% 
2. Prophylactic antibiotics 100% 
3. Hypothermia Nil 
 
 
 None among the forty four patients had any intraoperative 
complications. The average blood loss during the procedure in these 
procedures was 127.9ml and they received an average of 1614ml fluids 
intraoperatively. One patient required blood transfusion intraoperatively as 
the preoperative haemoglobin was less. 
Table 7 – blood loss and intravenous fluids 
Parameter Mean Standard deviation 
Blood loss 127.93 109.01 
Intra OP fluids 1614.25 653.17 
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POSTOPERATIVE PARAMETERS AND ADHERENCE TO PROTOCOL 
 
 Nasogastric tube and Initiation of diet within 24 hours 
 
One patient had the nasogastric tube removed immediately after 
surgery and the remaining forty three patients had nasogastric tube retained 
after surgery. 63.6% of patients had the nasogastric tube removed within 24 
hours of surgery. 70.45% patients were started on sips of fluids within 24 
hours. Among the patients for whom nasogastric tube was not removed and 
oral fluids were not started, three patients had blood stained nasogastric 
Transfusion
No transfusion Intra OP transfusion
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output, one patient had high output. For 5 patients nasogastric tube was 
retained due to surgeon preference and the remaining had abdominal 
distention and hence not started on fluids. 
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 Oral fluids by 48 hours 
By 48 hours, 72.7 percentage of patients were started on sips of fluids. 
Most common reason for not starting fluids orally remained to be persistent 
abdominal distention and reluctance of operating surgeon to start oral fluids. 
 
0 0.5 1 1.5 2 2.5 3 3.5 4 4.5 5
Surgeon preference High NG output
Blood tinged NG output Abdominal distention
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 Increase in oral fluid intake by 72 hours 
 
70.45% of patients tolerated clear liquids 30-60 ml per hour by 72 hours. One 
patient who was started on sips of fluidswas not progressed to clear fluids and 
had to be continued on sips of fluids as he had abdominal distention. 
Sips of fluids by 48 hours
started not started
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 Day of starting fluids as tolerated 
 
45.45% of the patients were tolerating liquids adequately by 4th postoperative 
day. By 5th day, 72.73% patients were tolerating fluids. 
Fluids as tolerated Number of patients Percentage 
Day 4 20 45.45 
Day 5 12 27.27 
Day 6 4 9.09 
Day 7 2 4.55 
> 7 Days 6 13.63 
 
Clear fluids by 72 hours
Started Not started
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 Initiation of solid diet 
 
45.45 percentage of patients were started on solid diet by fifth 
postoperative day. 70.45 percentage of patients tolerated normal diet by sixth 
postoperative day. 15.9 percentage of patients were not started on solid diet 
by 8 days. This group included the patients who developed complications in 
the postoperative period. One patient tolerated liquids but developed 
intolerance to solid diet and had a nasojejunal tube inserted for feeding.   
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Solid  Number of patients Percentage 
Day 5 20 45.45 
Day 6 11 25.00 
Day 7 4 9.09 
Day 8 2 4.55 
> 8 Days 7 15.91 
 
 
 
 Passage of flatus and stools 
72.73 percentage of patients had passed flatus by fifth postoperative day and 
all patients other than three who required re-exploration in the postoperative 
period had passed flatus by sixth postoperative day. 
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Day of passage 
of flatus 
Number of 
patients 
Percentage Cumulative 
percentage 
Day 2 3 6.82 6.82 
Day 3 6 13.64 20.45 
Day 4 9 20.45 40.91 
Day 5  14 31.82 72.73 
Day 6 9 20.45 93.18 
 6 days 3 6.82 100 
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70.45 percentage of patients passed stools by 6 days and 86 percentage of 
patients  had passed stools by 7th postoperative day. 
 
Day of passage 
of stools 
Number of 
patients 
Percentage Cumulative 
percentage 
Day 4 3 6.82 6.82 
Day 5 12 27.27 34.09 
Day 6 16 36.36 70.45 
Day 7  7 15.91 86.36 
Day 8 2 4.55 90.91 
>8 days 4 9.09 100 
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 Ambulation and postoperative pain relief 
All patients in the group followed the protocol for ambulation. All 
patients were made to sit up for at least half an hour in the initial 24 
hours and were encouraged to ambulate from the day of surgery. 
Ambulation was progressively increased over the postoperative period. 
 All patients received epidural analgesia for post op pain relief. 
None of the patients required any additional opioid for pain relief 
however few patients were given additional non-steroidal anti 
inflammatory drugs after assessment by the operating surgeon to top up 
analgesia. 72.73 percentage of patients had epidural analgesia retained 
till 4th post-operative day. Three patients had to be given morphine 
0 2 4 6 8 10 12 14 16
Day of passage of stool
>8 days Day 8 Day 7 Day 6 Day 5 Day 4
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subcutaneous doses for pain relief as the epidural had to be removed 
before 48 hours due to hypotension.  
 
Day of epidural removal Number of patients Percentage 
2 3 6.82 
3 9 20.45 
4 32 72.73 
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 Urinary catheter  
97 percent of patients had their urinary catheter removed by 4th postoperative 
day.  
Day of catheter removal Number of patients Percentage 
3 13 29.55 
4 30 68.18 
5 1 2.27 
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COMPLICATIONS 
 Immediate post-operative complications among the patients in ERAS 
group were studied and classified according to Clavien Dindo grading for 
postoperative complications into mild (grade 1 and 2) and severe (3 and 
4).Four patients required re-laparotomy (Grade 3b) and one patient re 
admission due to sub diaphragmatic collection requiring radiology guided drain 
placement (Grade 3a). Two patients developed wound infection which was 
managed with dressings (Grade 1) but prolonged their hospital stay. According 
to other studies, morbidity following subtotal gastrectomy ranges from 9 to 16 
percentage(104,105).  In our study percentage of patients requiring repeat 
laparotomy was 9.09%. There was no mortality among the group. 
 
 
Complications
No complications Grade 1 Grade 3a Grade 3b
79 
 
DISCUSSION 
 
 
 Demographic details of the ERAS group and control group were 
comparable. The mean age group among the groups were comparable to other 
international studies which showed predominance in the later age group with 
incidence increasing after 50 years of age.Multiple studies had also shown 
male preponderance for intestinal type of gastric cancer up to 2:1(106). The 
results of this study also showed similar distribution.  Majority of patients who 
were operated belonged to ASA 1 status with the percentage of patients with 
comorbid illnesses being very less. Due to the number of patients with 
comorbidities being very less any form of multivariate analysis to study the 
effect of comorbid illnesses on the outcome and relation to ERAS protocol 
could not be assessed. 
 This study proved that although there was a difference in postoperative 
hospital stay among patients following ERAS protocol for gastrectomy as 
compared to the conventional group, the difference was not statistically 
significant. This result was contradictory to similar international studies 
including a recent meta-analysis which showed significant reduction in 
postoperative hospital stay. This could be attributed to various possible 
reasons 
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1. There has not been any study reported from the Indian population. 
The difference in response to the ERAS protocol may be explained by 
the difference in the disease and patient characteristics and the 
reluctance to change from the conventional postop care resulting in 
reduced adherence to protocol. 
2. Sample size being small could be one reason for the difference in 
hospital stay not being statistically significant.  
3. Although ERAS was not being followed as a protocol, conventional 
care had incorporated various components of ERAS like nasogastric 
tube removal and early ambulation. Hence although not as a 
protocol, ERAS was partially being implemented in the conventional 
group, making the difference less significant. 
4. Another possible explanation is that patients were retained longer 
than the ideal required time due to error in recording the time when 
the patient was ‘fit for discharge’ as per the agreed protocol due to 
surgeon preference/patient reluctance to leave. 
 
Adherence to the ERAS protocol was 100 percent for the 
preoperative interventions. There were no intraoperative adverse 
events. Patients received an average of 1614ml fluids intraoperatively 
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which is comparable to other similar studies. During postoperative 
period, 63.6% of patients had nasogastric tube removed in 24 hours and 
70.45% patients were started on sips of fluids from the day of surgery. 
Reduced adherence to the removal of nasogastric tube was partly due to 
reluctance of the operating surgeon to start enteral feeds early and due 
to intolerance to enteral feeding detected as persistence of abdominal 
distention.72.7 percentage of patients were on sips of fluids by forty 
eight hours. Except for one patient among the group which was started 
on fluids all others had progressed to increased fluids orally. 72.73% 
patients were tolerating liquids as tolerated by fifth postoperative day. 
Six patients were requiring supplementary intravenous therapy even 
after 7 days postoperatively.These were the patients who required re-
exploration and one patient who had abdominal distention after starting 
fluids and had to have reinsertion of nasogastric tube. More than 70% of 
the patients were tolerating solid diet by sixth postoperative day. 
More than 70% patients had passed flatus by fifth postoperative day 
and more than 90% by sixth postoperative day.70% patients had passed 
stools by day 6 postoperatively and more than 90% had passed stools by 
day 8. 
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All patients were ambulated according to the protocol. All patients 
tolerated early ambulation. Pain relief was adequate with epidural 
analgesia with topped up with non-steroidal anti-inflammatory agents 
whenever required. For majority of patients (7.73%) the epidural 
analgesia was retained till fourth postoperative day. Urinary catheter 
was also retained till epidural was continued for majority of patients. 
Among the 44 patients, four patients required re-laparotomy of 
which three patients had duodenal stump leak and one patient had leak 
from the gastro jejunostomy site. One patient required readmission for 
sub-diaphragmatic collection. There was no mortality among the group 
and significant morbidity (Grade 3 and 4) was 9.09 percentage which 
was comparable to international literature. 
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LIMITATIONS 
1. As the sample size was small, statistical significance could not be 
demonstrated for the durationof hospital stay even though there was a 
observed difference. 
 
2. The study being an observational cohort and controls being historical 
cohort from preceding year, complete details could not be compared 
with the control group due to missing data. 
 
 
3. There is no definite consensus on ERAS protocol for upper 
gastrointestinal procedures. Different studies till now have used 
modified protocols from colorectal surgeries. 
 
4. As the sample size was less, multivariate analysis did not yield any 
significant results. 
 
 
5. The study was an observational study hence the protocol was not strictly 
implemented and had variations based on surgeon preference. 
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CONCLUSIONS 
 
1. The duration of hospital stay following subtotal gastrectomy is 
reduced when ERAS protocol has been followed however the 
difference was not statistically significant. 
 
2. Following an enhanced recovery protocol did not have any adverse 
effect on immediate postoperative morbidity or mortality. 
 
 
3. Overall compliance to the ERAS protocol was good however more 
studies and randomised control trials among Indian population will 
be required to formulate a proper guideline for ERAS in gastrectomy.  
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ENHANCED RECOVERY AFTER SURGERY (ERAS)     
A STUDY IN SUBTOTAL GASTRECTOMY PATIENTS                      
CHRISTIAN MEDICAL COLLEGE, VELLORE 
INFORMATION SHEET 
 
 
1. This study, in which you are being asked to participate, is being conducted to assess the effectiveness 
of enhanced recovery protocol after subtotal gastrectomy.  
 
2. As part of the study, data regarding your disease will be collected using interview method and from 
medical records. 
 
3. You will not have to undergo any special investigations in this study.  
 
4. You have to strictly follow the protocol already explained to you (also provided as a hand-out).  
 
5. Although we do not anticipate any adverse effects as a result of following this protocol, you will be 
constantly monitored for the development of any postoperative complications. 
 
6. I understand that I will not be offered any financial benefits because of participation in this study. 
 
7. The study details will be kept confidential in terms of personal information received from patients. 
Only the end results of the study will be published. The primary data collected will be kept in a 
database within General Surgery Unit 3, Christian Medical College, Vellore and will be accessible only 
to the doctors conducting the study. 
 
8. Consenting to be part of the study is purely voluntary. You can withdraw from the study at any given 
point of time and no explanation needs to be offered regarding the same. The further course of 
treatment will follow the standard protocol and in no way you will be penalised for it. 
 
9. You are eligible for the standard care offered to all patients in CMC, Vellore. None of the study 
patients will be deprived of the available therapies. 
 
10.   Any new information regarding the findings, if significant, will be notified to you.  
 
 
 
 
 
 
 
 
 
 
In the event of any further queries about the study, risks and benefits at any point of the study, 
you can contact Dr. Nandu Nair at 0416 – 2282079 / 9843666901. 
 
 
Informed consent form 
 
Study Title: ERAS Protocol for Subtotal Gastrectomy. 
 
Subject’s Initials: __________________ Subject’s Name: _________________________________________ 
 
Date of Birth / Age: ___________________________ 
 
Please mark   in the boxes after reading,  
 
 (i) I confirm that I have read and understood the information sheet dated _________ for the above study 
and have had the opportunity to ask questions. [ ] 
 
(ii) I understand that my participation in the study is voluntary and that I am free to withdraw at any time, 
without giving any reason, without my medical care or legal rights being affected. [ ] 
 
(iii) I understand that the cost of treatment and surgery I am being charged is identical to other patients not 
participating in this study. I am aware that I will not be offered any monetary / other benefits.  
 
 (iv) I understand that the Sponsor of the clinical trial, others working on the Sponsor’s behalf, the Ethics 
Committee and the regulatory authorities will not need my permission to look at my health records both in 
respect of the current study and any further research that may be conducted in relation to it, even if I 
withdraw from the trial. I agree to this access. [ ] 
 
(v) I understand that my identity will not be revealed in any information released to third parties or 
published. [ ] 
 
(vi) I agree not to restrict the use of any data or results that arise from this study provided such a use is only 
for scientific purpose(s) [ ] 
 
(vii) I agree to take part in the above study. [ ] 
 
 
 
 
 
 
Signature (or Thumb impression) of the Subject/Legally Acceptable Representative 
Date: _____/_____/______ 
Signatory’s Name: _________________________________     
 
Signature of the Investigator: ________________________ 
Date: _____/_____/______ 
Study Investigator’s Name: _________________________ 
 
Signature of the Witness: ___________________________ 
Date:_____/_____/_______ 
Name of the Witness: ______________________________ 
 
For Any Further clarifications contact: Dr. Nandu Nair at 0416 – 2282079 / 9843666901. 
ENHANCED RECOVERY AFTER SURGERY (ERAS) 
SUBTOTAL GASTRECTOMY           HAND-OUT FOR PATIENTS 
 
Aim of the leaflet 
The aim of this booklet is to help you understand what enhanced recovery is and how you can and 
will play an active part in your recovery. It outlines what you can expect to happen on a daily basis 
after your operation. 
 
What is Enhanced Recovery After Surgery? 
The aim of enhanced recovery is to improve your recovery from surgery and enable you to return to 
normal activities as early as you are able to. The programme focusses on making sure that patients 
are actively involved in their recovery. 
 
The key principles of enhanced recovery are:  
 Planning and preparation for surgery. 
 Reducing the stress of operation. 
 Structured perioperative and postoperative care (including pain relief). 
 Early mobilization and early feeding.  
 
Before your operation 
There are several things that you can do before your operation to help speed up your recovery 
afterwards. 
 
Stop smoking 
If you are a smoker, you should stop as soon as possible. The longer you are smoke-free before 
your operation, the smaller your risk of developing a chest problem after your operation. Stopping 
smoking will also improve your blood circulation and your body’s ability to heal. 
 
Healthy lungs - breathing exercises before your operation 
Having an anaesthetic can make you produce phlegm which you need to clear once you are awake 
after your operation. The breathing exercises will help you open up your lungs and clear any phlegm. 
You will be given a device called a “Spirometer” to help you perform the exercises correctly. You will 
be taught how to use the device. You should practice the breathing exercises daily before your 
operation. 
 
Preventing deep vein thrombosis 
To prevent blood clotting in your legs you will be asked to wear special stockings and you will be 
given an injection on the day before surgery. 
 
After your operation 
After the operation you will be on a urinary catheter. You may have a tube from the surgery site or 
a nasal tube which will only be put if found necessary and will be removed at the earliest. You will 
also have continuous infusion of pain medication through an epidural catheter on the back. 
 
Pain relief 
It is important that your pain is controlled after your operation so that you can: 
• Breathe deeply 
• Walk about 
• Feel relaxed 
• Sleep 
Apart from the continuous infusion of pain medication you will be given periodic injections for pain 
relief. You will be asked about your pain as part of your regular observations, but it is important that 
you tell those who are caring for you if you are in any pain at any other time.  
 
Your pain relief is very important – if you have pain, you must tell someone or you may 
have difficulty deep breathing, coughing or moving about. Failure to do so may lead to 
lung complications and may lengthen your recovery. 
 
Daily milestones 
After the surgery there a certain daily milestones that you are expected to achieve.  
 
Day of surgery 
1. Immediately after surgery you will be on oxygen through a mask. 
2. You will be allowed to take sips of water on the day after surgery once you are fully awake 
(6-8 hours after surgery). 
3. You are expected to sit up in your bed for at least half an hour. 
4. You are expected to do the breathing exercises on the spirometer at least ten times in an 
hour.   
5. If you had a nasal tube it will be taken off.  
 
Day 1 after surgery 
1. You will be allowed to take clear fluids. 
2. You are expected to ambulate from bed to chair and also walk with help for a duration of 30 
minutes.(minimum) 
3. You have to continue the breathing exercises.  
4. Your epidural infusion will be discontinued and the epidural as well as urinary catheter will 
be removed. 
 
Day 2 after surgery 
1. You are allowed to have thicker fluids.  
2. You are expected to walk for a minimum of half hour two times in the day. 
3. You have to continue breathing exercises. 
4. Your pain medications will be changed to tablets/suppositories. 
 
Day 3 after surgery 
1. You can have thick fluids and introduce some soft solid diet. 
2. You are expected to walk for half hour two times in the day.(minimum) 
3. Continue breathing exercises. 
 
Day 4 onwards 
 You can continue near normal activities. You are allowed to take normal diet. You will be 
discharged in the subsequent days if your pain is under control, you are able to have solid foods, 
you are able to ambulate well and your doctor feels that you are fit to be discharged.  
 
Do not stress about achieving all the above milestones. Each person responds differently. 
Your postoperative milestones may be altered from what is mentioned above, if your 
treating doctor feels so in your best interest. 
If you develop any postoperative complication you will be treated for it as is applicable for 
all post-operative patients.  
 
 
 For Any Further clarifications contact: Dr. Nandu Nair at 0416 – 2282079 / 9843666901.  
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DEMOGRAPHIC FACTORS 
 
 
PATIENT’S 
NAME:  
 
AGE: completed years    GENDER: M / F 
 
HOSPITAL NUMBER:  D.O.B:    
 
 
ADDRESS: 
 
 
TELEPHONE:      EMAIL ID:    
 
DATE OF ADMISSION:   
 
WEIGHT IN KG: 
HEIGHT IN CM: 
BMI: 
 
DISEASE PARAMETERS 
 
TISSUE DIAGNOSIS: 
 
TOTAL DURATION OF SYMPTOMS: 
 
SITE OF TUMOUR: 
 
SIZE OF TUMOUR: 
 
COMORBIDITIES:       DURATION 
 
1. DIABETES MELLITUS: Y/N 
2. HYPERTENSION:  Y/N 
3. CARDIAC DISEASE:  Y/N 
4. RESPIRATORY DISEASE: Y/N 
5. RENAL DISEASES:  Y/N 
6. OBESITY:   Y/N 
7. OTHERS: 
 
 
SMOKER:   Y/N   DURATION: 
ALCOHOLIC:  Y/N   DURATION: 
 
Hemoglobin:  
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PRE-TREATMENT STAGING. 
  TUMOR- T0,    Tis,     T1,     T2,     T3,      T4 
  NODES- NO NODES / LOCOREGIONAL/DISTANT 
  METASTASIS – M0, M1 
 
NEOADJUVANT CHEMO OR RADIOTHERAPY (PRE-OP) : Y/N 
  
INTRAOP 
 
ASA STATUS: 1/2/3/4/5 
 
DATE OF SURGERY: 
 
TYPE OF ANASTOMOSIS: 
1. HAND SEWN CONTINUOUS 
2. HAND SEWN INTERRUPTED 
3. STAPLED 
         – STAPLER SIZE____ 
 
COMPLICATIONS/COMMENTS: 
 
DURATION OF SURGERY: 
 
ESTIMATED BLOOD LOSS IN ML: 
INTRA OP TRANSFUSION :  Y/N IF YES NUMBER OF UNITS : 
POST OPERATIVE TRANSFUSION:         Y/N      IF YES NUMBER OF UNITS : 
INTRAOPERATIVE CRYSTALLOID USED: 
 
POSTOPERATIVE 
 
HISTOPATHOLOGY REPORT: 
POST OPERATIVE TNM STAGING:  
     TUMOR- T0,    Tis,     T1,     T2,     T3,      T4 
   NODES- NO NODES / LOCOREGIONAL/DISTANT 
  METASTASIS – M0, M1 
SITE OF TUMOUR: 
 
OUTCOME PARAMETERS 
 
DURATION OF HOSPITAL STAY: POD___ 
RE ADMISSION:   Y/N  IF YES, PLEASE SPECIFY REASON: 
 
 
DATE OF STARTING NORMAL DIET: 
 
DAY OF PASSAGE OF FLATUS: 
 
DAY OF PASSAGE OF FAECES: 
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DATE OF DISCHARGE: 
 
CLAVIEN-DINDO CLASSIFICATION OF COMPLICATIONS:   
 
 
REOPERATION REQUIRED:    Y/N. 
DETAILS OF REOPERATION: 
 
 
POST OP COMPLICATION  
Clavien Dindo Classification. 
Grades  Definition  
Grade I:  Any deviation from the normal postoperative course without the need for 
pharmacological treatment or surgical, endoscopic and radiological 
interventions.  
Allowed therapeutic regimens are: drugs as antiemetics, antipyretics, 
analgetics, diuretics and electrolytes and physiotherapy. This grade also 
includes wound infections opened at the bedside.  
Grade II:  Requiring pharmacological treatment with drugs other than such allowed for 
grade I complications. Blood transfusions and total parenteral nutrition are 
also included.  
Grade III:  Requiring surgical, endoscopic or radiological intervention  
Grade III-a:  Intervention not under general anesthesia  
Grade III-b:  Intervention under general anesthesia  
Grade IV:  Life-threatening complication (including CNS complications: brain 
haemorrhage, ischaemic stroke, subarachnoid bleeding, but excluding transient 
ischaemic attacks) requiring IC/ICU management.  
Grade IV-a:  Single organ dysfunction (including dialysis)  
Grade IV-b:  Multi-organ dysfunction  
Grade V:  Death of a patient  
Suffix 'd':  If the patients suffers from a complication at the time of discharge, the suffix “d” 
(for ‘disability’) is added to the respective grade of complication. This label 
indicates the need for a follow-up to fully evaluate the complication.  
 
 
 
 
ERAS PROTOCOLS FOLLOWED  
 
 
PREOPERATIVE 
 
COMPL
IANCE 
• Counselling the patient and relatives regarding the disease, proposed 
surgery, protocol for ERAS and its advantages. ( handout) 
• Provide the patients preoperative oral nutritional supplement. 
• Counselling patients to quit smoking and alcohol use.  
• Training patients to do incentive spirometry. 
• First dose of DVT prophylaxis. 
 
INTRAOPERATIVE  
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• Anaesthesia – Endotracheal intubation and GA + Thoracic Epidural. 
(other modes of regional analgesia if needed) 
• Antibiotic prophylaxis at induction of anaesthesia. 
• Avoid hypothermia during surgery 
• Intra OP fluid restriction. (in conjunction with anaesthetist) 
• Avoid NG tube and drains whenever possible (unless specifically deemed 
necessary) 
 
 
POSTOPERATIVE 
 
 
• Perioperative oxygen therapy – till 6hours post OP 
• Incentive spirometer once the patient is awake. 
• Analgesia – thoracic epidural analgesia + intravenous paracetamol till 48 
hours. Add on non opioid analgesics if pain scores more than 5 on a visual 
analogue score.  
• Diet – start on few sips of clear fluids on day of surgery followed by liquid 
diet from day 2 and soft solid diet from day 3 
• Removal of NG tube (if present) – within 24 hours 
• Removal of Urinary catheter – within 48 hours (along with epidural) 
• Ambulation – mobilize to chair on day of surgery, start progressive 
ambulation from day 2. 
• Continue DVT prophylaxis. 
 
Type of surgery and the limit of resection – standardised   
 
 Reason If any protocol not followed 
Patient No :  Name:   Hospital No: 
 
ERAS (ENHANCED RECOVERY AFTER SURGERY) FOLLOWING  
SUBTOTAL GASTRECTOMY 
Protocol for study patients 
 
Preoperative 
1. Counselling regarding procedure. 
2. Teach incentive spirometry. 
3. DVT prophylaxis with heparin / clexane. 
 
 
Please record whether following protocol was followed and give reason if unable 
to comply. 
Postoperative orders      Reasons if answer is No 
Oxygen 4L/min by mask for 6 hours. Y / N  
Sips of water once fully awake. Y / N  
Incentive spirometer once fully awake Y / N  
DVT prophylaxis. Y / N  
Any need for analgesia other than 
epidural and paracetamol   
Y / N  
 
Post op day 1         
NG tube if present – to be removed 
within 24 hours. 
Y / N  
Patient made to sit up for minimum 
half hour in bed. 
Y / N  
 
Post op day 2         
Urinary catheter removed within 48 
hours. 
Y / N 1. Well-functioning epidural analgesia 
2. If others specify - 
Increase oral sips Y / N  
Ambulation from bed to chair and 
starting to walk by evening.  
Y / N  
 
Intraoperative 
1. Epidural analgesia. 
2. Minimum intraop fluids. 
 
Patient No :  Name:   Hospital No: 
Post op day 3       Reasons if answer is No 
Remove epidural Y / N 1. Well-functioning epidural analgesia 
2. If others specify – 
 
Ambulation minimum twice a day Y / N  
 
Clear Liquids orally  
 
 
Y / N  
 
Post op day 4 
Liquids as tolerated 
 
Y / N  
Progressive ambulation. 
 
Y / N  
 
Post op day 5 
Soft solid diet 
 
Y / N  
Normal activity 
 
Y / N  
 
Patient may be discharged if : 
 Adequate oral diet without parenteral fluids 
 Normal body temperature 
 Pain is controlled with oral analgesics 
 Mobilizing comfortably 
 Normal gastrointestinal function (flatus and defecation) 
Ready for discharge date:                              Actually discharged on: 
Reason for delay:  
 
Please record any other relevant postoperative events 
 
 
sno grp age sex doa dis dod dos typ dur asa res op flu bld trn dia htn com cou hep inc
1 1 57 2 24/09/2014 08/10/2014 08/10/2014 25/09/2014 1 24 1 TRUE FALSE 2500 150 FALSE FALSE FALSE FALSE TRUE TRUE TRUE
2 1 54 1 14/09/2014 07/10/2014 07/10/2014 16/09/2014 1 6 1 TRUE FALSE 1500 500 FALSE FALSE FALSE FALSE TRUE TRUE TRUE
3 1 62 1 10/09/2014 15/09/2014 16/09/2014 11/09/2014 1 2 2 FALSE FALSE 9 9 FALSE FALSE TRUE TRUE TRUE TRUE TRUE
4 1 65 1 03/09/2014 08/09/2014 09/09/2014 04/09/2014 1 2 1 TRUE FALSE 1000 50 FALSE FALSE FALSE FALSE TRUE TRUE TRUE
5 1 64 1 13/08/2014 18/08/2014 19/08/2014 14/08/2014 1 12 2 FALSE FALSE 3000 100 FALSE FALSE TRUE FALSE TRUE TRUE TRUE
6 1 36 2 20/04/2014 27/04/2014 27/04/2014 22/04/2014 1 24 2 TRUE FALSE 1500 100 FALSE FALSE FALSE FALSE TRUE TRUE TRUE
7 1 55 1 21/04/2014 27/04/2014 29/04/2014 22/04/2014 1 6 1 TRUE FALSE 2000 300 FALSE FALSE FALSE FALSE TRUE TRUE TRUE
8 1 41 2 23/04/2014 29/04/2014 30/04/2014 24/04/2014 1 24 2 TRUE FALSE 1500 9 FALSE FALSE FALSE FALSE TRUE TRUE TRUE
9 1 48 2 26/02/2014 31/05/2014 01/06/2014 27/05/2014 1 72 1 TRUE FALSE 1500 9 FALSE FALSE FALSE FALSE TRUE TRUE TRUE
10 1 65 1 11/06/2014 10/07/2014 12/07/2014 12/06/2014 1 6 2 TRUE FALSE 1500 100 FALSE FALSE TRUE FALSE TRUE TRUE TRUE
11 1 27 2 22/06/2014 29/06/2014 29/06/2014 24/06/2014 1 1 1 TRUE FALSE 1000 50 FALSE FALSE FALSE FALSE TRUE TRUE TRUE
12 1 65 1 25/06/2014 01/07/2014 02/07/2014 26/06/2014 1 5 1 TRUE FALSE 2000 200 FALSE FALSE FALSE FALSE TRUE TRUE TRUE
13 1 54 1 23/07/2014 30/07/2014 31/07/2014 24/07/2014 1 6 1 FALSE FALSE 1500 9 FALSE FALSE FALSE FALSE TRUE TRUE TRUE
14 1 47 2 23/07/2014 31/07/2014 31/07/2014 24/07/2014 1 1 1 TRUE FALSE 1500 75 FALSE FALSE FALSE TRUE TRUE TRUE TRUE
15 1 78 1 04/08/2014 13/08/2014 13/08/2014 05/08/2014 1 24 2 TRUE FALSE 2000 100 FALSE FALSE TRUE FALSE TRUE TRUE TRUE
16 1 54 1 15/12/2014 21/12/2014 22/12/2014 16/12/2014 1 12 1 TRUE FALSE 1000 50 FALSE FALSE FALSE FALSE TRUE TRUE TRUE
17 1 60 1 05/11/2014 15/11/2014 15/11/2014 06/11/2014 1 2 2 TRUE FALSE 2500 150 FALSE FALSE FALSE FALSE TRUE TRUE TRUE
18 1 65 1 06/10/2014 16/10/2014 17/10/2014 09/10/2014 1 3 1 TRUE FALSE 2000 300 FALSE FALSE FALSE FALSE TRUE TRUE TRUE
19 1 56 1 19/10/2014 26/10/2014 26/10/2014 21/10/2014 1 24 1 TRUE FALSE 1500 50 FALSE FALSE FALSE FALSE TRUE TRUE TRUE
20 1 48 1 22/10/2014 27/10/2014 28/10/2014 23/10/2014 1 3 2 TRUE FALSE 1500 100 FALSE TRUE FALSE FALSE TRUE TRUE TRUE
21 1 52 1 22/10/2014 31/10/2014 01/11/2014 23/10/2014 1 24 1 TRUE FALSE 3000 100 FALSE FALSE FALSE FALSE TRUE TRUE TRUE
22 1 44 1 23/11/2014 29/11/2014 01/12/2014 25/11/2014 1 12 1 TRUE FALSE 2000 50 FALSE FALSE FALSE FALSE TRUE TRUE TRUE
23 1 39 1 30/11/2014 08/12/2014 08/12/2014 02/12/2014 1 4 1 TRUE FALSE 2000 50 FALSE FALSE FALSE FALSE TRUE TRUE TRUE
24 1 35 2 03/12/2014 24/12/2014 24/12/2014 04/12/2014 1 6 1 TRUE FALSE 1500 100 FALSE FALSE FALSE FALSE TRUE TRUE TRUE
25 1 45 1 15/12/2014 24/12/2014 25/12/2014 18/12/2014 1 1 2 TRUE FALSE 2500 100 FALSE FALSE FALSE TRUE TRUE TRUE TRUE
26 1 35 2 23/02/2015 15/03/2015 15/03/2015 24/02/2015 1 2 1 TRUE FALSE 1500 150 FALSE FALSE FALSE FALSE TRUE TRUE TRUE
27 1 52 2 12/11/2014 17/11/2014 18/11/2014 13/11/2014 1 4 1 TRUE FALSE 2500 100 FALSE FALSE FALSE FALSE TRUE TRUE TRUE
28 1 62 1 04/01/2015 17/01/2015 18/01/2015 06/01/2015 1 1 2 TRUE FALSE 1500 150 FALSE FALSE FALSE TRUE TRUE TRUE TRUE
29 1 46 2 07/01/2015 14/01/2015 15/01/2015 08/01/2015 1 4 1 TRUE FALSE 2000 200 FALSE FALSE FALSE FALSE TRUE TRUE TRUE
30 1 84 2 19/01/2015 25/01/2015 30/01/2015 20/01/2015 1 2 3 TRUE FALSE 1000 50 FALSE TRUE TRUE FALSE TRUE TRUE TRUE
31 1 67 1 11/02/2015 19/02/2015 20/02/2015 12/02/2015 1 4 2 TRUE FALSE 1500 200 FALSE FALSE FALSE FALSE TRUE TRUE TRUE
32 1 44 1 18/02/2015 24/02/2015 24/02/2015 19/02/2015 1 4 1 TRUE FALSE 9 9 FALSE FALSE FALSE FALSE TRUE TRUE TRUE
33 1 57 1 25/03/2015 30/03/2015 01/04/2015 26/03/2015 1 24 2 TRUE FALSE 1500 200 FALSE FALSE TRUE FALSE TRUE TRUE TRUE
34 1 57 2 01/04/2015 07/04/2015 07/04/2015 02/04/2015 1 8 1 FALSE FALSE 9 9 FALSE FALSE FALSE FALSE TRUE TRUE TRUE
35 1 57 2 02/03/2015 08/03/2015 08/03/2015 03/03/2015 1 7 2 FALSE FALSE 1500 50 TRUE FALSE FALSE FALSE TRUE TRUE TRUE
36 1 67 1 09/03/2015 22/03/2015 22/03/2015 10/03/2015 1 2 1 TRUE FALSE 2000 100 FALSE FALSE FALSE FALSE TRUE TRUE TRUE
37 1 60 1 09/03/2015 18/03/2015 18/03/2015 12/03/2015 1 4 1 TRUE FALSE 1500 100 FALSE FALSE FALSE FALSE TRUE TRUE TRUE
38 1 62 1 15/03/2015 23/03/2015 23/03/2015 17/03/2015 1 3 2 TRUE FALSE 2000 200 FALSE FALSE FALSE FALSE TRUE TRUE TRUE
39 1 52 1 15/03/2015 23/03/2015 24/03/2015 17/03/2015 1 2 1 TRUE FALSE 1500 100 FALSE FALSE FALSE FALSE TRUE TRUE TRUE
40 1 73 1 15/03/2015 23/03/2015 23/03/2015 17/03/2015 1 15 2 TRUE FALSE 1500 200 FALSE TRUE FALSE FALSE TRUE TRUE TRUE
41 1 34 1 04/03/2015 11/03/2015 11/03/2015 06/03/2015 1 8 2 TRUE FALSE 1500 150 FALSE FALSE FALSE TRUE TRUE TRUE TRUE
42 1 65 2 07/05/2014 13/05/2014 13/05/2014 08/05/2014 1 12 1 FALSE FALSE 1000 100 FALSE FALSE FALSE FALSE TRUE TRUE TRUE
43 1 57 1 12/05/2014 19/05/2014 19/05/2014 13/05/2014 1 5 1 TRUE FALSE 1500 300 FALSE FALSE FALSE FALSE TRUE TRUE TRUE
44 1 48 1 12/05/2014 18/05/2014 19/05/2014 13/05/2014 1 3 1 TRUE FALSE 2000 450 FALSE FALSE FALSE FALSE TRUE TRUE TRUE
45 2 33 2 02/01/2013 10/01/2013 10/01/2013 03/01/2013 1 1 FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
46 2 34 2 05/01/2013 17/01/2013 17/01/2013 10/01/2013 1 2 FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
47 2 28 1 13/01/2013 22/01/2013 22/01/2013 15/01/2013 1 1 FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
48 2 53 1 13/01/2013 21/01/2013 21/01/2013 15/01/2013 1 1 FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
49 2 45 2 16/01/2013 31/01/2013 31/01/2013 22/01/2013 1 1 FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
50 2 73 1 21/01/2013 04/02/2013 04/02/2013 29/01/2013 1 2 FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
51 2 41 1 23/01/2013 03/02/2013 03/02/2013 25/01/2013 1 1 FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
52 2 45 2 23/01/2013 04/02/2013 04/02/2013 29/01/2013 1 1 FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
53 2 65 1 30/01/2013 06/02/2013 06/02/2013 31/01/2013 1 1 FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
54 2 66 1 10/02/2013 17/02/2013 17/02/2013 12/02/2013 1 2 FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
55 2 40 1 28/02/2013 13/03/2013 13/03/2013 07/03/2013 1 1 FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
56 2 66 1 11/03/2013 25/03/2013 25/03/2013 12/03/2013 1 1 FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
57 2 74 1 09/04/2013 17/04/2013 17/04/2013 09/04/2013 1 2 FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
58 2 60 2 27/03/2013 05/04/2013 05/04/2013 28/03/2013 1 1 FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
59 2 53 1 10/04/2013 17/04/2013 17/04/2013 11/04/2013 1 1 FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
60 2 48 2 06/05/2013 15/05/2013 15/05/2013 07/05/2013 1 1 FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
61 2 43 2 02/06/2013 12/06/2013 12/06/2013 04/06/2013 1 2 FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
62 2 61 1 18/06/2013 28/06/2013 28/06/2013 20/06/2013 1 2 FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
63 2 44 1 26/06/2013 04/07/2013 04/07/2013 27/06/2013 1 2 FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
64 2 61 2 07/07/2013 16/07/2013 16/07/2013 09/07/2013 1 2 FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
65 2 36 1 10/07/2013 17/07/2013 17/07/2013 11/07/2013 1 1 FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
66 2 61 1 10/07/2013 16/07/2013 16/07/2013 11/07/2013 1 1 FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
67 2 73 1 13/07/2013 24/07/2013 24/07/2013 16/07/2013 1 2 FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
68 2 40 1 14/07/2013 22/07/2013 22/07/2013 16/07/2013 1 2 FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
69 2 54 1 10/08/2013 25/08/2013 25/08/2013 20/08/2013 1 1 FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
70 2 50 1 26/08/2013 03/09/2013 03/09/2013 27/08/2013 1 1 FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
71 2 62 1 01/09/2013 09/09/2013 09/09/2013 03/09/2013 1 1 FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
72 2 39 1 02/09/2013 09/09/2013 09/09/2013 02/09/2013 1 1 FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
73 2 53 2 04/09/2013 15/09/2013 15/09/2013 10/09/2013 1 1 FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
74 2 43 1 14/09/2013 23/09/2013 23/09/2013 19/09/2013 1 1 FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
75 2 37 2 15/09/2013 22/09/2013 22/09/2013 17/09/2013 1 2 FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
76 2 34 2 01/10/2013 06/10/2013 06/10/2013 01/10/2013 1 2 FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
77 2 73 2 10/10/2013 25/10/2013 25/10/2013 18/10/2013 1 1 FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
78 2 60 1 14/10/2013 25/10/2013 25/10/2013 18/10/2013 1 1 FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
79 2 54 1 16/10/2013 25/10/2013 25/10/2013 20/10/2013 1 1 FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
80 2 55 1 17/10/2013 02/11/2013 02/11/2013 22/10/2013 1 3 FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
81 2 36 1 17/10/2013 04/11/2013 04/11/2013 18/10/2013 1 1 FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
82 2 62 2 23/10/2013 11/11/2013 11/11/2013 29/10/2013 1 1 FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
83 2 29 1 23/10/2013 29/10/2013 29/10/2013 24/10/2013 1 1 FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
84 2 28 2 28/10/2013 04/11/2013 04/11/2013 01/11/2013 1 1 FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
85 2 47 2 14/11/2013 23/11/2013 23/11/2013 15/11/2013 1 2 FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
ted epi ng amb sip ana ora liq flu1 sol cat edr fla stl com1 fu
TRUE TRUE TRUE TRUE TRUE FALSE TRUE TRUE 9 9 9 9 9 9 TRUE FALSE
TRUE TRUE FALSE TRUE TRUE FALSE FALSE FALSE 9 9 9 9 9 9 TRUE FALSE
TRUE TRUE FALSE TRUE FALSE FALSE TRUE TRUE 4 5 4 3 4 5 FALSE FALSE
TRUE TRUE TRUE TRUE TRUE FALSE TRUE TRUE 4 5 3 3 3 4 FALSE FALSE
TRUE TRUE FALSE TRUE TRUE FALSE TRUE TRUE 4 5 4 4 4 5 FALSE FALSE
TRUE TRUE TRUE TRUE TRUE FALSE TRUE TRUE 4 5 4 4 5 6 FALSE FALSE
TRUE TRUE TRUE TRUE TRUE FALSE TRUE TRUE 4 5 4 4 5 5 TRUE FALSE
TRUE TRUE TRUE TRUE TRUE FALSE TRUE FALSE 5 6 3 3 4 5 FALSE FALSE
TRUE TRUE FALSE TRUE TRUE FALSE TRUE TRUE 4 5 3 3 3 5 FALSE FALSE
TRUE TRUE TRUE TRUE TRUE FALSE FALSE FALSE 9 9 4 4 5 6 TRUE FALSE
TRUE TRUE TRUE TRUE TRUE FALSE TRUE TRUE 4 5 3 4 5 6 FALSE FALSE
TRUE TRUE TRUE TRUE TRUE FALSE TRUE TRUE 4 5 3 3 2 5 FALSE FALSE
TRUE TRUE TRUE TRUE TRUE FALSE TRUE FALSE 6 7 4 4 6 7 FALSE FALSE
TRUE TRUE TRUE TRUE TRUE FALSE TRUE TRUE 5 6 4 4 5 6 FALSE TRUE
TRUE TRUE FALSE TRUE FALSE FALSE FALSE FALSE 7 8 4 4 4 7 FALSE FALSE
TRUE TRUE TRUE TRUE TRUE FALSE TRUE TRUE 4 5 4 4 3 5 FALSE FALSE
TRUE TRUE FALSE TRUE FALSE FALSE FALSE FALSE 8 9 3 3 4 6 FALSE FALSE
TRUE TRUE FALSE TRUE FALSE FALSE FALSE FALSE 7 8 4 4 3 6 FALSE FALSE
TRUE TRUE TRUE TRUE TRUE FALSE TRUE TRUE 4 5 4 4 3 4 FALSE FALSE
TRUE TRUE TRUE TRUE TRUE FALSE TRUE TRUE 4 5 4 4 4 5 FALSE FALSE
TRUE TRUE TRUE TRUE TRUE FALSE TRUE TRUE 4 5 4 4 5 6 FALSE FALSE
TRUE TRUE TRUE TRUE TRUE FALSE TRUE TRUE 5 6 4 4 4 6 FALSE FALSE
TRUE TRUE FALSE TRUE FALSE FALSE TRUE TRUE 4 5 4 4 4 5 FALSE FALSE
TRUE TRUE TRUE TRUE TRUE FALSE TRUE FALSE 5 9 4 4 6 8 TRUE FALSE
TRUE TRUE FALSE TRUE FALSE FALSE FALSE FALSE 6 7 4 4 6 6 FALSE FALSE
TRUE TRUE FALSE TRUE FALSE FALSE FALSE FALSE 9 9 4 4 9 9 TRUE FALSE
TRUE TRUE TRUE TRUE TRUE FALSE TRUE TRUE 4 5 4 4 3 5 FALSE FALSE
TRUE TRUE FALSE TRUE FALSE FALSE FALSE FALSE 9 9 4 4 6 8 TRUE FALSE
TRUE TRUE FALSE TRUE FALSE FALSE FALSE TRUE 5 6 3 3 6 6 FALSE FALSE
TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE 5 6 4 4 5 6 FALSE FALSE
TRUE TRUE TRUE TRUE TRUE FALSE TRUE TRUE 6 7 4 4 2 7 FALSE FALSE
TRUE TRUE TRUE TRUE TRUE FALSE TRUE TRUE 4 5 4 4 6 6 FALSE FALSE
TRUE TRUE TRUE TRUE TRUE FALSE TRUE TRUE 4 5 4 4 5 5 FALSE FALSE
TRUE TRUE TRUE TRUE TRUE FALSE TRUE TRUE 4 5 4 4 4 4 FALSE FALSE
TRUE TRUE FALSE TRUE FALSE FALSE FALSE FALSE 5 6 3 3 5 6 FALSE FALSE
TRUE TRUE TRUE TRUE TRUE FALSE TRUE TRUE 4 5 4 4 5 9 TRUE FALSE
TRUE TRUE TRUE TRUE TRUE FALSE TRUE TRUE 5 6 4 4 5 5 FALSE FALSE
TRUE TRUE FALSE TRUE FALSE FALSE FALSE FALSE 6 7 4 4 6 7 FALSE FALSE
TRUE TRUE TRUE TRUE TRUE FALSE TRUE TRUE 5 6 4 4 2 7 FALSE FALSE
TRUE TRUE TRUE TRUE TRUE FALSE TRUE TRUE 5 6 9 4 6 7 FALSE FALSE
TRUE TRUE FALSE TRUE FALSE FALSE FALSE TRUE 5 6 3 3 6 7 FALSE FALSE
TRUE TRUE TRUE TRUE TRUE FALSE TRUE TRUE 4 5 4 4 5 6 FALSE FALSE
TRUE TRUE TRUE TRUE TRUE FALSE TRUE TRUE 5 6 3 2 5 6 FALSE FALSE
TRUE TRUE FALSE TRUE FALSE FALSE TRUE TRUE 4 5 5 4 5 6 FALSE FALSE
FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE FALSE
